Liver pathology in Wilson's disease: From copper overload to cirrhosis

被引:57
|
作者
Gerosa, C. [1 ]
Fanni, D. [1 ]
Congiu, T. [1 ]
Piras, M. [1 ]
Cau, F. [2 ]
Moi, M. [1 ]
Faa, G. [1 ]
机构
[1] Univ Cagliari AOU Cagliari, Div Pathol, Cagliari, Italy
[2] San Gavino Hosp, ATS, Div Pathol, San Gavino, Italy
关键词
METAL-BINDING DOMAINS; TRANSPORTER ATP7B; EXPRESSION; DIAGNOSIS; ZINC; LOCALIZATION; STEATOSIS; MUTATIONS; INSIGHTS; THERAPY;
D O I
10.1016/j.jinorgbio.2019.01.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Wilson's disease (WD) is a genetic metabolic disease strictly associated with liver cirrhosis. In this review, the genetic bases of the disease are discussed, with emphasis on the role of ATP7B (the Wilson disease protein) dysfunction as a determinant factor of systemic copper overload. Regarding the different multiple mutations described in WD patients, the peculiarity of Sardinian population is highlighted, Sardinians carrying a rare deletion in the promoter (5' UTR) of the WD gene. The role of epigenetic changes in the clinical presentation and evolution of liver disease in WD patients is also discussed, nutrition probably representing a relevantly risk factor in WD patients. The role of transmission electron microscopy in the diagnosis of WD-related liver disease is underlined. Mitochondrial changes, increased peroxisomes fat droplets, lipolysosomes and intranuclear glycogen inclusions are reported as the most frequent ultrastructural changes in the liver of WD carriers. The role of histochemical stains for copper is analyzed, and the Timm's method is suggested as the most sensitive one for revealing hepatic copper overload in all stage of WD. The marked variability of the histological liver changes occurring in WD is underlined simple steatosis may represent the only pathological changes, frequently associated with glycogenated nuclei. Mallory-Denk bodies lipogranulomas alcoholic and non-alcoholic fatty liver disease ending with bridging fibrosis and cirrhosis. Finally, the reversal of fibrosis as a possible therapeutic objective in WD is discussed.
引用
收藏
页码:106 / 111
页数:6
相关论文
共 50 条
  • [41] Analysis of risk factors for fatty liver disease in children with Wilson's disease
    Jia, Shu-Pei
    Wang, Mei-Xia
    Tao, Zhuang
    Gao, Yan-Nan
    Yu, Gu-Ran
    Yang, Wen-Ming
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (08) : 1046 - 1053
  • [42] Long-term outcome of Wilson's disease complicated by liver disease
    Arai, Satoko
    Kogiso, Tomomi
    Ogasawara, Yuri
    Sagawa, Takaomi
    Taniai, Makiko
    Tokushige, Katsutoshi
    JGH OPEN, 2021, 5 (07): : 793 - 800
  • [43] New tools for Wilson's disease diagnosis: exchangeable copper fraction
    Wohnant, France
    Djebrani-Oussedik, Nouzha
    Poujois, Aurelia
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [44] Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease
    Lozano Herrero, Jesus
    Munoz Bertran, Eduardo
    Ortega Gonzalez, Isabel
    Gomez Espin, Rosa
    Lopez Espin, Maria Isabel
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2012, 35 (10): : 704 - 707
  • [45] Phenotype-genotype correlations in patients with Wilson's disease
    Ferenci, Peter
    HUMAN DISORDERS OF COPPER METABOLISM II, 2014, 1315 : 1 - 5
  • [46] Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the Liver
    Shribman, Samuel
    Marjot, Thomas
    Sharif, Abubakar
    Vimalesvaran, Sunitha
    Ala, Aftab
    Alexander, Graeme
    Dhawan, Anil
    Dooley, James
    Gillett, Godfrey T.
    Kelly, Deirdre
    McNeill, Alisdair
    Warner, Thomas T.
    Wheater, Valerie
    Griffiths, William
    Bandmann, Oliver
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (06): : 560 - 575
  • [47] Comparative assessment of clinical rating scales in Wilson's disease
    Volpert, Hanna M.
    Pfeiffenberger, Jan
    Groener, Jan B.
    Stremmel, Wolfgang
    Gotthardt, Daniel N.
    Schaefer, Mark
    Weiss, Karl Heinz
    Weiler, Markus
    BMC NEUROLOGY, 2017, 17
  • [48] Effect of liver transplantation on brain magnetic resonance imaging pathology in Wilson disease: a case report
    Litwin, Tomasz
    Dziezyc, Karolina
    Poniatowska, Renato
    Czlonkowska, Anna
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2013, 47 (04) : 393 - 397
  • [49] Zinc monotherapy is effective in Wilson's disease patients with mild liver disease diagnosed in childhood: a retrospective study
    Ranucci, Giusy
    Di Dato, Fabiola
    Spagnuolo, Maria Immacolata
    Vajro, Pietro
    Iorio, Raffaele
    ORPHANET JOURNAL OF RARE DISEASES, 2014, 9
  • [50] The Prevalence of Wilson's Disease: An Update
    Sandahl, Thomas Damgaard
    Laursen, Tea Lund
    Munk, Ditte Emilie
    Vilstrup, Hendrik
    Weiss, Karl Heinz
    Ott, Peter
    HEPATOLOGY, 2020, 71 (02) : 722 - 732